Not only VEGF but DLL4 is also known to impair efficient delivery of anti-cancer drugs and to enhance chemoresistance in pancreatic cancer model due to induction of defective tumor angiogenesis [33]. Here, VEGFA is linked to pancreatic neoplasm.